Eli Lilly: CHMP Issues Positive Opinion For Jaypirca - Quick Facts
28/2 14:38
(RTTNews) - Eli Lilly and Company (LLY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for Jaypirca, a non-covalent Bruton's tyrosine kinase inhibitor, for the treatment of adult patients with relapsed o...